Victory Capital Management
VERA icon

Victory Capital Management’s Vera Therapeutics VERA Stock Holding History

Victory Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$908K Buy
21,171
+202
+1% +$7.53K ﹤0.01% 1935
2026
Q1 		$844K Buy
20,969
+6,203
+42% +$267K ﹤0.01% 1901
2025
Q4 		$748K Sell
14,766
-3,148
-18% -$112K ﹤0.01% 1941
2025
Q3 		$521K Sell
17,914
-141
-0.8% -$3.26K ﹤0.01% 2033
2025
Q2 		$425K Sell
18,055
-203,685
-92% -$4.58M ﹤0.01% 2084
2025
Q1 		$5.33M Sell
221,740
-13,527
-6% -$435K 0.01% 1261
2024
Q4 		$9.95M Buy
235,267
+197,014
+515% +$8.72M 0.01% 1088
2024
Q3 		$1.69M Buy
38,253
+4,546
+13% +$173K ﹤0.01% 1535
2024
Q2 		$1.22M Buy
33,707
+22,560
+202% +$895K ﹤0.01% 1618
2024
Q1 		$481K Buy
+11,147
New +$397K ﹤0.01% 1993

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Victory Capital Management's VERA Position: Q2 2026 in Review

Victory Capital Management increased its Vera Therapeutics (VERA) stake by 0.96% in Q2 2026, buying an estimated $7.53K and bringing the position to 21,171 shares worth $908K. The position accounts for ﹤0.01% of the portfolio, ranked #1935.

Victory Capital Management first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.95M in Q4 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Victory Capital Management held 21,171 shares of Vera Therapeutics worth $908K as of Q2 2026.
  • Victory Capital Management bought 202 Vera Therapeutics shares in Q2 2026, an estimated $7.53K.
  • Vera Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1935 holding.
  • Victory Capital Management first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Victory Capital Management's Vera Therapeutics position peaked at $9.95M in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.